{"component": "definition", "props": {"groups": [{"snippet": "means the U.S. Federal Food, Drug, and Cosmetic Act, as amended.", "snippet_links": [{"key": "the-us", "type": "clause", "offset": [6, 13]}, {"key": "as-amended", "type": "definition", "offset": [53, 63]}], "samples": [{"hash": "3K7NWaBFK1k", "uri": "/contracts/3K7NWaBFK1k#fda-act", "label": "Merger Agreement (Metacrine, Inc.)", "score": 33.6789855957, "published": true}, {"hash": "g3Pmjid9PTg", "uri": "/contracts/g3Pmjid9PTg#fda-act", "label": "Merger Agreement (La Jolla Pharmaceutical Co)", "score": 33.5256690979, "published": true}, {"hash": "4gc4mgBGXKP", "uri": "/contracts/4gc4mgBGXKP#fda-act", "label": "Merger Agreement (La Jolla Pharmaceutical Co)", "score": 33.5229301453, "published": true}], "size": 52, "hash": "15d94b4ac1ac869ee04df67334510fea", "id": 1}, {"snippet": "means the U.S. Food, Drug and Cosmetic Act of 1938, as it may be superseded or amended from time to time.", "snippet_links": [{"key": "the-us", "type": "clause", "offset": [6, 13]}, {"key": "from-time-to-time", "type": "clause", "offset": [87, 104]}], "samples": [{"hash": "kth5aqzbLwy", "uri": "/contracts/kth5aqzbLwy#fda-act", "label": "Asset Purchase Agreement (Vivus Inc)", "score": 24.1540050507, "published": true}, {"hash": "hI76QpadYGU", "uri": "/contracts/hI76QpadYGU#fda-act", "label": "Asset Purchase Agreement (Vivus Inc)", "score": 21.0, "published": true}, {"hash": "eKp5jQ9hIun", "uri": "/contracts/eKp5jQ9hIun#fda-act", "label": "Asset Purchase Agreement (Kv Pharmaceutical Co /De/)", "score": 21.0, "published": true}], "size": 38, "hash": "140c43b87e434622999bfaf7854fb0ee", "id": 2}, {"snippet": "means the United States Federal Food, Drug, and Cosmetic Act, 21 U.S.C. \u00a7 301 et seq., as amended from time to time, together with any rules, regulations and requirements promulgated thereunder (including all additions, supplements, extensions, and modifications thereto).", "snippet_links": [{"key": "united-states-federal", "type": "definition", "offset": [10, 31]}, {"key": "as-amended", "type": "definition", "offset": [87, 97]}, {"key": "from-time-to-time", "type": "clause", "offset": [98, 115]}, {"key": "regulations-and-requirements", "type": "clause", "offset": [142, 170]}], "samples": [{"hash": "dbhufOV1eVC", "uri": "/contracts/dbhufOV1eVC#fda-act", "label": "Membership Interest Purchase Agreement (Amneal Pharmaceuticals, Inc.)", "score": 32.0307998657, "published": true}, {"hash": "dvWvgcwUHTI", "uri": "/contracts/dvWvgcwUHTI#fda-act", "label": "Agreement and Plan of Merger", "score": 31.3408622742, "published": true}, {"hash": "cb8BuQfbCZA", "uri": "/contracts/cb8BuQfbCZA#fda-act", "label": "Merger Agreement (Amag Pharmaceuticals Inc.)", "score": 29.9472961426, "published": true}], "size": 35, "hash": "8e41de0df5ef0953b48085923c221aab", "id": 3}, {"snippet": "means the Federal Food, Drug and Cosmetic Act and applicable implementing regulations issued by the FDA, including, as applicable, those requirements relating to the FDA\u2019s current good manufacturing and quality system practices, good laboratory practices and good clinical practices and investigational use.", "snippet_links": [{"key": "implementing-regulations", "type": "definition", "offset": [61, 85]}, {"key": "issued-by", "type": "definition", "offset": [86, 95]}, {"key": "the-fda", "type": "clause", "offset": [96, 103]}, {"key": "relating-to", "type": "definition", "offset": [150, 161]}, {"key": "quality-system", "type": "definition", "offset": [203, 217]}, {"key": "good-laboratory-practices", "type": "definition", "offset": [229, 254]}, {"key": "good-clinical-practices", "type": "definition", "offset": [259, 282]}], "samples": [{"hash": "3mEKUC2jzPv", "uri": "/contracts/3mEKUC2jzPv#fda-act", "label": "Asset Purchase Agreement (Avalo Therapeutics, Inc.)", "score": 35.3627662659, "published": true}, {"hash": "fhWj4Kket96", "uri": "/contracts/fhWj4Kket96#fda-act", "label": "Asset Purchase Agreement (Elevation Oncology, Inc.)", "score": 32.364818573, "published": true}, {"hash": "fIXJhwYnP5z", "uri": "/contracts/fIXJhwYnP5z#fda-act", "label": "Asset Purchase Agreement", "score": 31.3408622742, "published": true}], "size": 19, "hash": "2f1d2918b7299d7aed2c351a1b106c1c", "id": 4}, {"snippet": "means the Federal Food, Drug, and Cosmetic Act, as amended.", "snippet_links": [{"key": "as-amended", "type": "definition", "offset": [48, 58]}], "samples": [{"hash": "k3hKhPpU8rS", "uri": "/contracts/k3hKhPpU8rS#fda-act", "label": "Manufacturing and Supply Agreement (Pacira BioSciences, Inc.)", "score": 37.1533203125, "published": true}, {"hash": "1rJlykOCTNi", "uri": "/contracts/1rJlykOCTNi#fda-act", "label": "Manufacturing and Supply Agreement (Pacira BioSciences, Inc.)", "score": 37.1533203125, "published": true}, {"hash": "1ZBlL6Ut0w8", "uri": "/contracts/1ZBlL6Ut0w8#fda-act", "label": "Manufacturing and Supply Agreement (Pacira BioSciences, Inc.)", "score": 33.1587944031, "published": true}], "size": 9, "hash": "7a81dbd9fb7690bccc6ebcf849327672", "id": 5}, {"snippet": "means the Federal Food, Drug and Cosmetic Act.", "snippet_links": [], "samples": [{"hash": "fkP3cixGnQX", "uri": "/contracts/fkP3cixGnQX#fda-act", "label": "Merger Agreement (Aclaris Therapeutics, Inc.)", "score": 28.8494186401, "published": true}, {"hash": "bE6aiO7Gy3", "uri": "/contracts/bE6aiO7Gy3#fda-act", "label": "Merger Agreement (Sucampo Pharmaceuticals, Inc.)", "score": 28.3347015381, "published": true}], "size": 6, "hash": "6ea1d88d99bf6a7f511f92e46b6d2039", "id": 6}, {"snippet": "means the Food, Drug and Cosmetics Act of 1938, as amended, supplemented or replaced. \u201cFinal Inventory Value\u201d shall have the meaning set forth in Section 2.7(d).", "snippet_links": [{"key": "as-amended", "type": "definition", "offset": [48, 58]}, {"key": "final-inventory-value", "type": "definition", "offset": [87, 108]}], "samples": [{"hash": "8mfujN2by8U", "uri": "http://pdf.secdatabase.com/193/0001144204-17-024566.pdf", "label": "pdf.secdatabase.com", "score": 10.3251199722, "published": false}, {"hash": "8yaIhVJxgml", "uri": "https://investor.anipharmaceuticals.com/static-files/08dbc336-ee61-40c3-a22b-0008609389f0", "label": "investor.anipharmaceuticals.com", "score": 10.0184803009, "published": false}, {"hash": "gtW4dPsupAQ", "uri": "https://investor.anipharmaceuticals.com/static-files/aa3ff2c4-34be-4487-a9d0-1664c5850707", "label": "investor.anipharmaceuticals.com", "score": 10.0171117783, "published": false}], "size": 4, "hash": "ab718a3017cb75e6925f29ee3c01cfad", "id": 7}, {"snippet": "means the United States Food, Drug and Cosmetic Act and applicable regulations promulgated thereunder.", "snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [6, 23]}, {"key": "applicable-regulations", "type": "definition", "offset": [56, 78]}], "samples": [{"hash": "h4Cmmyi0WSD", "uri": "/contracts/h4Cmmyi0WSD#fda-act", "label": "Research and Development Agreement (Iomed Inc)", "score": 18.0, "published": true}, {"hash": "eetz7pTHbYD", "uri": "/contracts/eetz7pTHbYD#fda-act", "label": "Research and Development Agreement (Iomed Inc)", "score": 18.0, "published": true}, {"hash": "dsZjb40k0fI", "uri": "/contracts/dsZjb40k0fI#fda-act", "label": "Research and Development Agreement (Iomed Inc)", "score": 18.0, "published": true}], "size": 4, "hash": "25976c8358c4db64528125fa8e8469ff", "id": 8}, {"snippet": "means the U.S. Food, Drug and Cosmetic Act of 1938, as amended from time to time, and its Canadian counterpart, the Food and Drugs Act (Canada), as they may be superseded or amended from time to time.", "snippet_links": [{"key": "the-us", "type": "clause", "offset": [6, 13]}, {"key": "as-amended", "type": "definition", "offset": [52, 62]}, {"key": "from-time-to-time", "type": "clause", "offset": [63, 80]}, {"key": "food-and-drugs-act", "type": "definition", "offset": [116, 134]}], "samples": [{"hash": "cdHKOw4N9lF", "uri": "/contracts/cdHKOw4N9lF#fda-act", "label": "Asset Purchase Agreement (Elan Corp PLC)", "score": 18.0, "published": true}, {"hash": "4Tmw8keZlI3", "uri": "/contracts/4Tmw8keZlI3#fda-act", "label": "Asset Purchase Agreement (Enzon Inc)", "score": 18.0, "published": true}, {"hash": "kYM6DbkYKEG", "uri": "https://investor.enzon.com/static-files/7836e0ce-4683-46a6-9009-a16cbfc0e0a0", "label": "investor.enzon.com", "score": 8.5249824524, "published": false}], "size": 3, "hash": "be4104aa609c182efc8dfb2c3d616053", "id": 9}, {"snippet": "means the Federal Food, Drug and Cosmetic Act, as amended. \u201cFDA Ethics Policy\u201d has the meaning set forth in Section 3.14(j). \u201cFinancial Statements\u201d has the meaning set forth in Section 3.06(a)(iii). \u201cFIRPTA Statement\u201d has the meaning set forth in Section 6.09.", "snippet_links": [{"key": "as-amended", "type": "definition", "offset": [47, 57]}, {"key": "fda-ethics-policy", "type": "definition", "offset": [60, 77]}, {"key": "financial-statements", "type": "definition", "offset": [126, 146]}, {"key": "firpta-statement", "type": "definition", "offset": [200, 216]}], "samples": [{"hash": "ewVXxNAc5SC", "uri": "https://investors.abeonatherapeutics.com/all-sec-filings/content/0001144204-15-049914/0001144204-15-049914.pdf", "label": "investors.abeonatherapeutics.com", "score": 9.1273097992, "published": false}, {"hash": "2mX69Bn9klF", "uri": "https://investors.abeonatherapeutics.com/all-sec-filings/content/0001144204-15-049282/0001144204-15-049282.pdf", "label": "investors.abeonatherapeutics.com", "score": 9.1273097992, "published": false}], "size": 3, "hash": "752879ff4415f9f2427f3214524263c6", "id": 10}], "next_curs": "ClQSTmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjALEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIQZmRhLWFjdCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means the U.S. Federal Food, Drug, and Cosmetic Act, as amended.", "title": "FDA Act", "size": 200, "id": "fda-act", "examples": ["The Product is not adulterated or misbranded within the meaning of the <strong>FDA Act</strong> or any similar governmental act or Applicable Law of any jurisdiction.", "The Product is not adulterated or misbranded within the meaning of the <strong>FDA Act</strong> or any similar governmental act or Law of any jurisdiction.", "The Company is currently conducting, and has at all times conducted, its business and operations in compliance in all material respects with each applicable Law, including the <strong>FDA Act</strong> and applicable implementing regulations, orders, policies and guidance issued by the FDA thereunder.", "The Existing Products have not been adulterated or misbranded within the meaning of the <strong>FDA Act</strong>, or within the meaning of any applicable Law.", "No Existing Product is or was, at the time of any introduction, an article that is or was prohibited from introduction into interstate commerce under the <strong>FDA Act</strong>, including Sections 301, 501, 502, 510, 515 or 801 thereof.", "The Inventory has been stored in compliance with all Laws and is not adulterated or mislabeled, misbranded or unsafe within the meaning of the <strong>FDA Act</strong> (including the Pesticide and Food Additive Amendment of 1958) and the regulations thereunder.", "Battelle represents and warrants that, after due inquiry, it has not and will not knowingly employ, contract with or retain any person directly or indirectly to perform services under this Agreement, if such person is debarred by the FDA under 21 USC 335a(k) of the <strong>FDA Act</strong> or a regulator in the EU under similar laws.", "All Active Ingredients, Components and Material for Product to be sold in the EU / U.S. will be procured, by Company or Supplier, in accordance with the applicable approved U.S. ANDA/NDA and the <strong>FDA Act</strong> and European Regulatory Dossier.", "Neither the Company nor, to the Knowledge of the Company, any manufacturers of the Company Products, have received any warning or advisory letters from the FDA or received information from the FDA or other applicable Governmental Authority indicating that the Company Products are not in compliance with the <strong>FDA Act</strong> or any other applicable Laws.", "DSM represents and warrants to Cubist that (a) all Product supplied to Cubist hereunder shall at the time of such delivery, not be adulterated within the meaning of the Federal Food, Drug and Cosmetic Act of 1941, as amended (<strong>FDA ACT</strong>), as such <strong>FDA Act</strong> is effective at the time of delivery, and will not be an article which may not, under the provisions of the <strong>FDA Act</strong>, be introduced into interstate commerce."], "related": [["fdc-act", "FD&C Act", "FD&amp;C Act"], ["fmc-act", "FMC Act", "FMC Act"], ["acnc-act", "ACNC Act", "ACNC Act"], ["fda", "FDA", "FDA"], ["hitech-act", "HITECH Act", "HITECH Act"]], "related_snippets": [], "updated": "2026-04-24T04:48:06+00:00"}, "json": true, "cursor": ""}}